gentamicin c1a has been researched along with norfloxacin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Athar, M; Jain, VK; Jha, PC; Mehta, V; Modi, K; Panchal, M | 1 |
| Gruber, JD; Pachaiyappan, B; Schmidt, MG; Wang, B; Woster, PM; Zhang, YM | 1 |
| Hong, J; Jung, JH; Kim, A; Kim, MJ; Liu, Y; Noh, TH; Wei, X | 1 |
| Bai, L; Deng, J; Feng, L; Lv, Z; Wang, Y; Xu, Z; Zhang, F; Zhao, S | 1 |
| Bukhari, SNA; Mallesha, N; Manukumar, HM; Qin, HL; Rakesh, KP; Vivek, HK; Wang, SM; Zha, GF | 1 |
| Guo, H | 1 |
| Zhang, B | 1 |
| Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
| Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH | 1 |
| Akhtar, S; Ansari, MM; Ghosh, JK; Mitra, K; Pant, G; Pratap Verma, D; Saroj, J; Singh, BN; Verma, NK | 1 |
3 review(s) available for gentamicin c1a and norfloxacin
| Article | Year |
|---|---|
Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Benzofurans; Humans; Structure-Activity Relationship | 2019 |
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
8 other study(ies) available for gentamicin c1a and norfloxacin
| Article | Year |
|---|---|
Efficiently functionalized oxacalix[4]arenes: Synthesis, characterization and exploration of their biological profile as novel HDAC inhibitors.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Binding Sites; Calixarenes; Cell Line, Tumor; Cell Survival; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary | 2016 |
Antibacterial Diamines Targeting Bacterial Membranes.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Cell Membrane; Cell Membrane Permeability; Chemistry Techniques, Synthetic; Diamines; Drug Evaluation, Preclinical; Drug Interactions; Escherichia coli; HEK293 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 2016 |
Synthesis and antibacterial evaluation of hamacanthin B analogues.
Topics: Anti-Bacterial Agents; Carbon-13 Magnetic Resonance Spectroscopy; Chromatography, High Pressure Liquid; Circular Dichroism; Enterococcus faecalis; Escherichia coli; Indole Alkaloids; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Pyrazines; Stereoisomerism; Structure-Activity Relationship | 2016 |
Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections.
Topics: Bacterial Infections; Biofilms; Drug Resistance, Multiple; Electron Transport Chain Complex Proteins; Fluorides; Methicillin-Resistant Staphylococcus aureus; Molecular Docking Simulation; Oxidation-Reduction; Staphylococcal Infections; Sulfinic Acids; Sulfones | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship | 2021 |
Tandem Repeat of a Short Human Chemerin-Derived Peptide and Its Nontoxic d-Lysine-Containing Enantiomer Display Broad-Spectrum Antimicrobial and Antitubercular Activities.
Topics: Animals; Antimicrobial Peptides; Antitubercular Agents; Cell Survival; Chemokines; Dose-Response Relationship, Drug; Erythrocytes; Humans; Lysine; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Pseudomonas Infections; Stereoisomerism; Structure-Activity Relationship; THP-1 Cells | 2021 |